On Saturday, January 24, 2026, Imam Al-Hujjah Hospital hosted a specialized scientific lecture as part of its ongoing educational and professional development programs, titled:
“The Role of Pioglitazone in the Management of Type 2 Diabetes Beyond HbA1c Reduction”
The lecture was delivered by Dr. Akram Abdulhassan Al-Abbadi, Specialist in Internal Medicine, Respiratory, Gastrointestinal, Endocrine, and Diabetes Disorders, and was attended by a large number of physicians, medical and nursing staff, as well as healthcare professionals with an interest in the field.
The presentation addressed the latest scientific updates in strategies for managing type 2 diabetes, highlighting the therapeutic role of pioglitazone in improving disease control, reducing complications, and enhancing long-term health outcomes—benefits that extend beyond its effect on lowering HbA1c levels.
This event forms part of the hospital’s ongoing efforts to support continuing medical education and to further develop the competencies of healthcare professionals, ultimately contributing to improved quality of care for patients.
